can semaglutide cause rash How to Treat a Injection Site Reaction A patient has been on

Overlap strategy (3 to 4 day gap): Administer final Wegovy dose on day 0

Peptide Vials (Tirzepatide, 10 mg each): 8 weeks (2.55 mg/wk): ~30 mg total 3 vials 12 weeks (2.57.5 mg/wk): ~60 mg total 6 vials 16 weeks (2.510 mg/wk): ~100 mg total 10 vials Insulin Syringes (U100, 1 mL): 8 weeks: 8 syringes (1/week) 12 weeks: 16 syringes (~1.3/week avg) 16 weeks: 24 syringes (~1.5/week avg) Bacteriostatic Water (10 mL bottles): Use 2.0 mL per vial for reconstitution

2 Reductions have been seen in lesional skin and in bloodstream circulation as measured by gene expression analysis and enzyme-linked immunosorbent assay (ELISA)

Thyroid C-cell Tumors FDA GLP-1 MTC (MTC) (MEN 2) 2